Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.468 EUR | -0.43% | -5.65% | +4.93% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | 44.63K 47.78K | Sales 2022 | 12.23K 13.1K | Capitalization | 5.91M 6.33M |
---|---|---|---|---|---|
Net income 2021 | -4M -4.28M | Net income 2022 | - 0 | EV / Sales 2021 | 429 x |
Net Debt 2021 | 121K 130K | Net cash position 2022 | 1.84M 1.97M | EV / Sales 2022 | 333 x |
P/E ratio 2021 |
-4.68
x | P/E ratio 2022 |
-7.12
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 40.86% |
1 day | -0.43% | ||
1 week | -5.65% | ||
Current month | +25.13% | ||
1 month | +54.97% | ||
3 months | -10.00% | ||
6 months | -68.16% | ||
Current year | +4.93% |
Managers | Title | Age | Since |
---|---|---|---|
Bruno Rosen
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ralph Bieneck
BRD | Director/Board Member | 56 | - |
Arne Segler
CHM | Chairman | - | - |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.468 | -0.43% | 239 |
24-04-23 | 0.47 | +0.86% | 239 |
24-04-22 | 0.466 | -0.85% | 750 |
24-04-19 | 0.47 | 0.00% | 385 |
24-04-18 | 0.47 | -5.24% | 385 |
Delayed Quote Xetra, April 24, 2024 at 11:36 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+4.93% | 2.57M | |
+4.09% | 43.84B | |
+47.81% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- T5O Stock